Bai Li
- Molecular Biology
- Cancer Research
- Pharmacology top 10%
- Oncology
- Hepatology top 10%
- Topics
- Healthcare and Venom Research (6 papers)Cancer Mechanisms and Therapy (5 papers)Hepatocellular Carcinoma Treatment and Prognosis (4 papers)
- Partner nations
- ChinaUnited KingdomAustria
In The Last Decade
Bai Li
42 papers receiving 691 citations
Peers
Comparison fields: 5 of 116
- Molecular Biology 277
- Cancer Research 136
- Pharmacology 117
- Oncology 116
- Hepatology 103
Countries citing papers authored by Bai Li
This map shows the geographic impact of Bai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bai Li more than expected).
Fields of papers citing papers by Bai Li
This network shows the impact of papers produced by Bai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bai Li. The network helps show where Bai Li may publish in the future.
Co-authorship network of co-authors of Bai Li
This figure shows the co-authorship network connecting the top 25 collaborators of Bai Li. A scholar is included among the top collaborators of Bai Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bai Li. Bai Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 4 | |
| 3 | 13 | |
| 4 | 4 | |
| 5 | 11 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | 65 | |
| 9 | 42 | |
| 10 | Triple-controlled oncolytic adenovirus expressing melittin to exert inhibitory efficacy on hepatocellular carcinoma. | 28 |
| 11 | 82 | |
| 12 | 7 | |
| 13 | 27 | |
| 14 | 8 | |
| 15 | 26 | |
| 16 | 36 | |
| 17 | 12 | |
| 18 | 28 | |
| 19 | The immune-potentiating effect of fomes officinalis polysaccharides | 3 |
| 20 | EFFECTS OF DEHYDRATION ON THE P-WAVE VELOCITY OF ANORTHOSITE AT HIGH PRESSURE AND HIGH TEMPERATURE | 2 |
About Bai Li
Bai Li is a scholar working on Computational Mathematics, Hepatology and Complementary and alternative medicine, having authored 44 papers that have together received 703 indexed citations. Recurring topics across this work include Healthcare and Venom Research (6 papers), Cancer Mechanisms and Therapy (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). The work is most often cited by research in Hepatology (103 citations), Complementary and alternative medicine (88 citations) and Cancer Research (136 citations). Bai Li has collaborated with scholars based in China, United Kingdom and Austria. Frequent co-authors include Changquan Ling, Xiaofeng Zhai, Zubin Yu, Jia Fan, Weiping Zhou, Qing-Hui Zhou, Fanfu Fang, Feng Shen, Yunke Yang and Zhe Chen. Their work appears in journals such as Cancer, Scientific Reports and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.